Orthofix announces new president of Bone Growth Therapies

Jason Shallenberger, Orthofix’s new president of Bone Growth Therapies [Image courtesy of Orthofix]Orthofix Medical (NASDAQ:OFIX) is promoting from within to fill a new business president position at the company.

The Lewisville, Texax–base spine and ortho tech company announced today that it moving its Bone Growth Therapies business out from under the leadership of its Spine business.

Jason Shallenberger, previously the VP of U.S. sales and marketing for the Bone Growth Therapies business, is now Orthofix’s president of Bone Growth Therapies.

“Jason has led sales and marketing for this successful franchise for a number of years,” Orthofix President and CEO Massimo Calafiore said in a news release. “Under his guidance, the sales team has produced quarter-after-quarter of double-digit growth in 2023. I am confident he will do an amazing job as President and continue to contribute greatly to the success of Orthofix.”

Shallenberger said he wa…

Read more
  • 0

Endoscopic ultrasound company EndoSound has a new CEO

New EndoSound CEO Scott Aldrich Jr. [Image from Scott Aldrich Jr. on LinkedIn]EndoSound announced today that it appointed Scott Aldrich Jr. as its new CEO in a move that went into effect on Feb. 1.

Dr. Stephen Steinberg, who previously served as president and CEO, remains on the Portland, Oregon–based company’s leadership team as chief medical officer.

Aldrich most recently served as an independent consultant focusing on medical device strategy, commercialization and operations. According to LinkedIn, he also served as VP of commercial & strategy at Motus GI from January 2023 to July 2023, having been VP of global marketing & strategy from September 2019 until the start of 2023.

In a news release, EndoSound said Aldrich brings operational and commercial leadership abilities paired with experience in both interventional gastroenterology and medical device imaging. His experience also spans startups and small/mid-cap companies, both privately an…

Read more
  • 0

AbbVie president and COO to move into corner office

Robert Michael is slated to become AbbVie’s CEO in July 2024. [Image courtesy of AbbVie]

AbbVie (NYSE: ABBV) recently announced that its board of directors has decided to promote the company’s president and COO Robert A. Michael into the corner office.

Michael will succeed Richard A. Gonzalez, who is retiring as CEO on July 1. Gonzalez will stay as executive chair of AbbVie’s board.

“On behalf of AbbVie’s board, I am extremely excited that Rob has agreed to serve as AbbVie’s next CEO,” Gonzalez said in a Feb. 20 news release.

“As a key member of the executive leadership team, he has had a tremendous impact on AbbVie. From establishing our financial planning organization, to the development of our diversified business strategy, to successfully navigating the end of exclusivity for Humira in the U.S., Rob has been integral to AbbVie’s impact since…

Read more
  • 0

Philips tabs Stryker controller as next CFO

Philips proposed to appoint Charlotte Hanneman as its next CFO. [Image courtesy of Philips]Philips (NYSE: PHG) + announced today that it proposes to appoint Charlotte Hanneman as a member of its management board as chief financial officer (CFO).

The Dutch medtech giant proposed to make the appointment effective on Oct. 1, 2024. It must submit its proposal to the annual general meeting of shareholders scheduled for May 7, 2024.

Philips expects to have Hanneman join as a member of its executive committee on June 1, 2024. This begins her induction and transition into the role as she succeeds current CFO Abhijit Bhattacharya on Oct. 1, following his retirement.

Roy Jakobs, CEO of Royal Philips said: “I would like to thank Abhijit for his significant contribution to the transformation of Philips into a health technology company. His dedication and leadership have made a major impact throughout his long 37-year career in…

Read more
  • 0

Integra LifeSciences CEO Jan De Witte to retire

Incoming Integra Lifesciences CEO Jan D. De Witte [Image courtesy of Integra]Integra LifeSciences (Nasdaq: IART) + announced today that President and CEO Jan De Witte informed the board of his intention to retire.

De Witte plans to retire following the appointment of a successor. Integra anticipates that appointment to come by the end of 2024. Additionally, the company appointed Stuart Essig, Integra chair, to the role of executive chair, effective immediately.As executive chair, Essig’s role entails driving shareholder value and ensuring an effective transition.

Essig became a non-executive chair in 2012 and previously served as Integra’s CEO from 1997 to 2012.

“We are grateful to Jan for his leadership and commitment to Integra and the role he has played in advancing our portfolio and building upon our legacy of innovation,” Essig said in a news release. “Jan’s personal decision to retire from Integra…

Read more
  • 0

Osso VR picks new CEO as former leader transitions to new role

Osso VR announced today that it appointed Greg Born as its new CEO as Justin Barad transitions out of the role into a new position.

Born’s focus in the corner office centers around driving growth and expansion in the procedural training space. Osso VR develops academic programs with virtual reality (VR) training modules and simulations. Its platform, which features Osso Enterprise and Osso Academy, gives healthcare professionals ways to share, practice and learn new skills using hyper-realistic VR training.

The company offers modules in specialties including orthopedics, urology, cardiology, pediatrics and trauma. It also works with a number of leading medical device manufacturers worldwide. Earlier this month, it even launched a controller-free feature for its platforms.

Justin Barad founded the company and served as CEO for the past seven years. He intends to move into a chief strategy officer role to spearhead innovation efforts.

“A…

Read more
  • 0

A high-ranking BD executive is set to retire

Dave Hickey. [Image from BD]BD (NYSE: BDX) + announced today that its EVP and President of Life Sciences, Dave Hickey, intends to retire this year.

Hickey plans for his retirement to go into effect on July 1, 2024. He originally joined BD in 2014, serving as president of Diagnostic Systems. He took over as president of Integrated Diagnostic Solutions in 2019 and began leading the Life Sciences segment in January 2021.

Prior to joining BD, Hickey held a range of executive leadership positions at Siemens Healthcare.

Read: Dave Hickey explains BD’s diagnostics business strategy.

“For over a decade at BD, Dave has demonstrated a strong, strategic and innovative approach, empowering his teams to deliver impactful results through a growth mindset and developing incredible talent and next-gen leaders at BD,” said Tom Polen, chair, CEO and president. “We wish him a…

Read more
  • 0

Mitral valve repair company NeoChord has a new CEO

New NeoChord CEO Todd Berg. [Image from Metavention]NeoChord announced that it appointed Todd Berg as its new CEO to oversee its programs for mitral valve repair.

Minneapolis-based NeoChord develops technology for the delivery of artificial chords to treat mitral valve regurgitation. In the role, Berg oversees the clinical and commercial programs for the transeptal and transapical repair of damaged mitral valve chords.

The company’s DS1000 transapical (TA) chord repair system holds commercial marketing authorization in Europe. Its use spans the placement of more than 5,000 successful neochordae in more than 2,000 patients. The company’s NeXus transseptal (TS) chord repair system incorporates the same proprietary, suture-based anchor elements as DS1000. It’s currently in feasibility clinical trials.

Taking over the oversight of these products, Berg brings with him significant medtech experience over more than 30 years. He most recently serv…

Read more
  • 0

The Bakken Medical Devices Center gets a new director

Hubert Lim, PhD, the incoming director of the Bakken Medical Devices Center at the University of Minnesota. [Image courtesy of BMDC]The Bakken Medical Devices Center at the University of Minnesota announced today that a longtime biomedical engineering professor will become its new director.

Hubert Lim, PhD, has been at the University of Minnesota for 14 years. He’s presently a professor in the Biomedical Engineering and Otolaryngology Departments at the university’s College of Science and Engineering.

In addition, Lim is active in the medtech startup community. He’s the chief scientific officer of Neuromod Devices (Dublin and Lisle, Illinois), which is developing a tinnitus treatment device) and chief scientific officer of SecondWave Systems (Minneapolis), which is developing a wearable ultrasound device for treating immune disorders.

Initially established in 2007 and located in the Mayo Building on the University of Minnesota Twin Cities …

Read more
  • 0

QuidelOrtho terminates CEO

QuidelOrtho’s interim CEO Michael Iskra (left) and interim president Robert Bujarsku (right). [Image courtesy of QuidelOrtho]QuidelOrtho announced today that it terminated President and CEO Douglas Bryant, effective immediately.

The company said the decision came after a “comprehensive evaluation.” Bryant also resigned from the board of directors, effective today.

QuidelOrtho’s board formed the Office of the Chief Executive Officer on February 17 to ensure business continuity and effective leadership. The Office of the CEO is led by EVP and Chief Commercial Officer Michael Iskra, EVP and Chief Operating Officer Robert Bujarski and CFO Joseph Busky.

Iskra was appointed interim CEO and Bujarski interim president, both effective today. The pair will continue to fulfill their current responsibilities while assuming additional duties in their interim roles.

“Now is the time for a change in leadership that can accelerate our initiat…

Read more
  • 0

A Medtronic EVP is leaving amid latest reorganization

Bob White [Image courtesy of Medtronic]Bob White, the EVP and president of Medtronic’s Medical Surgical portfolio, will be leaving the company due to a new round of reorganization.

CEO Geoff Martha announced that White was leaving at the end of the company’s Q3 earnings call this morning. Martha explained plans to end Medtronic’s ventilator business and combine what remains of Patient Monitoring and Respiratory Interventions into one business unit called Acute Care and Monitoring (ACM).

“He’s been such an impactful and important leader for the company for a long time, Martha said of White. “While the friendship will remain strong, we’re definitely going to miss working with him day to day. I want to wish him well. And know this comes from the board of directors and the executive committee and everybody at Medtronic who’s interacted with Bob — just a high ethical leader and just a good guy, and we wish him well.”…

Read more
  • 0

CMR Surgical picks J&J veteran to lead efforts in Asia, Middle East, Africa

New CMR Surgical President and CCO for Asia Pacific, the Middle East and Africa, Sushobhan Dasgupta. [Image from Sushobhan Dasgupta on LinkedIn]CMR Surgical announced that it appointed Sushobhan Dasgupta as president and CCO for Asia Pacific, the Middle East and Africa.

Dasgupta offers more than 30 years of experience across diverse medtech markets globally. Notably, he spent three decades with Johnson & Johnson MedTech. Now, the veteran of the industry — and the region — comes to CMR to help drive operations around its surgical robot in the region.

Most recently, Dasgupta served as vice chair and global president at Shalby Limited, a healthcare group in India. There, he had responsibility for driving Shalby’s acquired orthopedic implant business, based in California. He also provided strategic oversight to the company’s base hospital business.

Dasgupta’s 30-year tenure at J&J MedTech included stints as a member of the J&J Orth…

Read more
  • 0